论文部分内容阅读
目的:比较阿奇霉素和头孢唑肟在治疗老年支气管肺炎中的效果,为老年支气管肺炎的药物治疗提供依据。方法:由2011年1月至2013年6月间就诊于我院的老年支气管炎患者中随机抽取100例患者,并随机分为研究组(50例)和对照组(50例),其中研究组患者给予阿奇霉素治疗,对照组患者采用头孢唑肟治疗,经过一段时间的治疗后收集两组患者的治疗结果。结果:研究组患者的治疗有效率为98.00%,对照组的治疗有效率为88.00%。研究组患者的治疗效果好于对照组,两组之间差异显著,p<0.05,具有统计学意义。结论:对于老年支气管肺炎而言,阿奇霉素的治疗效果要好于头孢唑肟,在临床实践中的应用价值更大。
Objective: To compare the effects of azithromycin and ceftizoxime in the treatment of bronchopneumonia in the elderly and provide the basis for drug treatment of bronchopneumonia in the elderly. Methods: A total of 100 patients with senile bronchitis were enrolled in our hospital from January 2011 to June 2013 and were randomly divided into study group (50 cases) and control group (50 cases). The study group Patients were treated with azithromycin, and patients in the control group were treated with ceftizoxime. After a period of treatment, the treatment outcomes of both groups were collected. Results: The treatment effective rate was 98.00% in the study group and 88.00% in the control group. The treatment effect of the study group was better than that of the control group, with significant difference between the two groups (p <0.05, statistically significant). CONCLUSIONS: Azithromycin is superior to ceftizoxime for elderly bronchopneumonia and is of greater value in clinical practice.